Inactive Instrument

Press Releases Standard BioTools Inc.

Equities

SLGC

US83444K1051

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Standard BioTools Stockholders Approve Merger with SomaLogic	Jan. 04	AQ
SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting	Jan. 04	PR
Madryn Asset Management Demands SomaLogic’s Board Address Repeated, Unprecedented Adjournments of Tainted Special Meeting	Jan. 04	BU
Madryn Asset Management Addresses SomaLogic’s Apparent Failure to Obtain Requisite Shareholder Support for the Proposed Merger with Standard BioTools	Jan. 04	BU
Proxy Advisory Firm Egan-Jones Recommends SomaLogic Shareholders Vote Against Proposed Merger with Standard BioTools	Jan. 03	BU
SomaLogic Urges Stockholders to Maximize Value of Their Investment by Voting "FOR" Pending Merger with Standard BioTools	Jan. 02	PR
Madryn Asset Management Highlights Increasing Public Shareholder Opposition to Value-Destructive SomaLogic Merger and Calls on Company to Make Additional Disclosures	Dec. 29	BU
Leading Independent Proxy Advisory Firms Glass Lewis and ISS Both Recommend SomaLogic Stockholders Vote "FOR" Proposed Merger with Standard BioTools	Dec. 29	PR
SomaLogic Board Reiterates Value-Maximizing Transaction with Standard BioTools is in Best Interests of All Stockholders	Dec. 29	PR
Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic's Proposed Merger with Standard BioTools	Dec. 28	PR
SomaLogic : Merger Agreement - Form 8-K	Dec. 26	PU
SomaLogic Issues Statement Correcting Madryn Asset Management's Misleading Disclosure	Dec. 26	PR
Madryn Asset Management Releases Evidence That SomaLogic Ran a Flawed and Incomplete Review of Alternatives	Dec. 26	BU
Madryn Asset Management Sends Letter to ISS Respectfully Requesting it Withdraw “Cautionary Support” for SomaLogic’s Value-Destructive Proposed Merger with Standard BioTools	Dec. 24	BU
Madryn Asset Management Reiterates Alternative Path to SomaLogic’s Value-Destructive Proposed Merger with Standard BioTools	Dec. 22	BU
ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools	Dec. 22	AQ
Madryn Asset Management Highlights Newly-Disclosed Conflicts of Interest Related to Proposed SomaLogic Merger with Standard BioTools	Dec. 22	BU
SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools	Dec. 21	AQ
Madryn Asset Management Issues Letter to Shareholders Correcting False and Misleading Statements in SomaLogic’s Recent Investor Presentation	Dec. 21	BU
Skye Fund III Issues Letter Regarding Opposition to SomaLogic’s Proposed Merger with Standard BioTools	Dec. 20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Standard BioTools Inc.

Equities

SLGC

US83444K1051

Press Releases

Filters